Talaromycosis

Last updated
Talaromycosis
Other namesPenicillium marneffei, [1] penicilliosis [2] or penicillosis [3]
Specialty Infectious diseases
Symptoms skin lesions, fever, anaemia, large lymph glands, large liver. [2] Sometimes none. [4]
Causes Talaromyces marneffei [1]
Risk factors HIV/AIDS, long-term steroids, organ transplant, old age, malnutrition [4]
Diagnostic method Microscopy, culture, biopsy, [2] medical imaging [4]
Differential diagnosis Tuberculosis, histoplasmosis [4]
Prevention Itraconazole [1]
Treatment Antifungals [1]
Medication Amphotericin B followed by itraconazole or voriconazole [1]
Prognosis Often fatal if untreated [1]
Frequencyunknown [1] M>F [4]

Talaromycosis is a fungal infection that presents with painless skin lesions of the face and neck, as well as an associated fever, anaemia, and enlargement of the lymph glands and liver. [1] [5]

Contents

It is caused by the fungus Talaromyces marneffei , which is found in soil and decomposing organic matter. [1] The infection is thought to be contracted by inhaling the fungus from the environment, though the environmental source of the organism is not known. [2] People already suffering from a weakened immune system due to conditions such as HIV/AIDS, cancer, organ transplant, long-term steroid use, old age, malnutrition or autoimmune disease are typically the ones to contract this infection. [2] [4] It generally does not affect healthy people and does not spread from person to person. [2] Diagnosis is usually made by identification of the fungus from clinical specimens, either by microscopy or culture. Biopsies of skin lesions, lymph nodes, and bone marrow demonstrate the presence of organisms on histopathology. [2] Medical imaging may reveal shadows in the lungs. [4] The disease can look similar to tuberculosis and histoplasmosis. [4]

Talaromycosis may be prevented in people at high risk, using the antifungal medication itraconazole, and is treatable with amphotericin B followed by itraconazole or voriconazole. [2] The disease is fatal in 75% of those not given treatment. [2]

Talaromycosis is endemic exclusively to southeast Asia (including southern China and eastern India), and particularly in young farmers. [2] The exact number of people in the world affected is not known. [2] Men are affected more than women. [4] The first natural human case of talaromycosis was reported in 1973 in an American minister with Hodgkin's disease who lived in Southeast Asia. [6]

Signs and symptoms

There may be no symptoms, [4] or talaromycosis may present with small painless skin lesions. [2] The head and neck are most often affected. [2] Other features include: fever, general discomfort, weight loss, cough, difficulty breathing, diarrhoea, abdominal pain, swelling of the spleen (splenomegaly), liver swelling (hepatomegaly), swollen lymph nodes (lymphadenopathy), [2] and anemia. [2] [4] There may be no symptoms. [4]

In those without HIV infection, the lungs, liver, and mouth are usually affected, with systemic infection rarely occurring. [2] The skin lesions are also often smooth. [2] The disease tends to present differently in those with HIV infection; they are more likely to experience widespread infection. [2] Their skin lesions however, are usually dented in the centre and can appear similar to molluscum contagiosum. [2] [4]

Cause

Talaromycosis is usually caused by T. marneffei, however, other species of the Talaromyces genus are also known to cause the disease in rare cases. [2]

Risk factors

Talaromycosis rarely affects healthy people and generally occurs in people who are already sick and unable to fight infection such as HIV/AIDS, cancer, organ transplant, long-term steroid use, old age, malnutrition or autoimmune disease. [2] [4]

Mechanism

The infection is thought to be acquired through breathing in the organism from the environment. However, the exact source of infection is not known. [2] The infection is not spread person-to-person. [2] In Thailand, talaromycosis is more common during the rainy season; rain may promote the proliferation of the fungus in the environment. [2]

Diagnosis

There is no accurate fast serological test. [3] Diagnosis relies on identifying Talaromyces marneffei in cultures from clinical specimens such as sputum, blood, skin scrapings, lymph node, and bone marrow, [4] by which time the disease is in the late-stage. [7] Fungi in blood are found in half of case. [4]

Non-specific laboratory findings may show evidence of the fungus invading tissue, such as low platelets due to bone marrow infiltration, and elevated transaminases due to liver involvement. [8]

Biopsies of skin lesions, lymph nodes, and bone marrow demonstrate the presence of organisms on histopathology. [8] Intracellular and extracellular forms are oval and have a characteristic transverse septum. [4] In culture, colonies are powdery green and produce red pigment; however, cultures are negative in a significant number of cases. [7]

Medical imaging may reveal shadows in the lungs. [4]

Differential diagnosis

The disease can look similar to tuberculosis and histoplasmosis [4]

Treatment

Talaromycosis may be prevented in people at high risk, using the antifungal medication itraconazole, and is treatable with amphotericin B followed by itraconazole or voriconazole. [2]

Outcomes

With treatment, less than 25% of those affected die. [2] Without treatment, more than 75% will die. [2]

Epidemiology

The exact number of people in the world affected is not known. [2] Once considered rare, its occurrence increased due to HIV/AIDS to become the third most common opportunistic infection (after extrapulmonary tuberculosis and cryptococcosis) in HIV-positive individuals within the endemic area of Southeast Asia. [2] [5] While incidence in those with HIV began to decrease due to antiretroviral treatment, the number of cases in those without HIV began to rise in some endemic areas since the mid-1990s, likely due to improved diagnosis and an increase in other conditions that reduce immunity. [2] The disease has been found to be more common in young farmers. [2] Men are affected more than women. [4]

History

T. marneffei was first isolated from a bamboo rat in Vietnam in 1956. [6] Three years later, it was described by Gabriel Segretain as a new species with disease potential. [6] The first natural human case of talaromycosis was reported in 1973 in an American minister with Hodgkin's disease who lived in Southeast Asia. [6]

Research

An antigen assay has been developed to detect a key virulence factor Mp1p that has been shown to have a high specificity for Talaromyces marneffei. [7]

Related Research Articles

<span class="mw-page-title-main">Coccidioidomycosis</span> Fungal infection

Coccidioidomycosis, commonly known as cocci, Valley fever, as well as California fever, desert rheumatism, or San Joaquin Valley fever, is a mammalian fungal disease caused by Coccidioides immitis or Coccidioides posadasii. Coccidioidomycosis is endemic in certain parts of the United States in Arizona, California, Nevada, New Mexico, Texas, Utah, and northern Mexico.

<span class="mw-page-title-main">Histoplasmosis</span> Human disease

Histoplasmosis is a fungal infection caused by Histoplasma capsulatum. Symptoms of this infection vary greatly, but the disease affects primarily the lungs. Occasionally, other organs are affected; called disseminated histoplasmosis, it can be fatal if left untreated.

<i>Talaromyces marneffei</i> Species of fungus

Talaromyces marneffei, formerly called Penicillium marneffei, was identified in 1956. The organism is endemic to southeast Asia where it is an important cause of opportunistic infections in those with HIV/AIDS-related immunodeficiency. Incidence of T. marneffei infections has increased due to a rise in HIV infection rates in the region.

<span class="mw-page-title-main">Cryptococcosis</span> Potentially fatal fungal disease

Cryptococcosis is a potentially fatal fungal infection of mainly the lungs, presenting as a pneumonia, and brain, where it appears as a meningitis. Cough, difficulty breathing, chest pain and fever are seen when the lungs are infected. When the brain is infected, symptoms include headache, fever, neck pain, nausea and vomiting, light sensitivity and confusion or changes in behavior. It can also affect other parts of the body including skin, where it may appear as several fluid-filled nodules with dead tissue.

<i>Coccidioides immitis</i> Species of fungus

Coccidioides immitis is a pathogenic fungus that resides in the soil in certain parts of the southwestern United States, northern Mexico, and a few other areas in the Western Hemisphere.

<span class="mw-page-title-main">Fungal infection</span> Disease caused by fungi to animals or humans

Fungal infection, also known as mycosis, is a disease caused by fungi. Different types are traditionally divided according to the part of the body affected; superficial, subcutaneous, and systemic. Superficial fungal infections include common tinea of the skin, such as tinea of the body, groin, hands, feet and beard, and yeast infections such as pityriasis versicolor. Subcutaneous types include eumycetoma and chromoblastomycosis, which generally affect tissues in and beneath the skin. Systemic fungal infections are more serious and include cryptococcosis, histoplasmosis, pneumocystis pneumonia, aspergillosis and mucormycosis. Signs and symptoms range widely. There is usually a rash with superficial infection. Fungal infection within the skin or under the skin may present with a lump and skin changes. Pneumonia-like symptoms or meningitis may occur with a deeper or systemic infection.

WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents was first produced in 1990 by the World Health Organization and updated in September 2005. It is an approach for use in resource limited settings and is widely used in Africa and Asia and has been a useful research tool in studies of progression to symptomatic HIV disease.

The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. The system is used to allow the government to handle epidemic statistics and define who receives US government assistance.

<span class="mw-page-title-main">Pneumocystosis</span> Medical condition

Pneumocystosis is a fungal infection that most often presents as Pneumocystis pneumonia in people with HIV/AIDS or poor immunity. It usually causes cough, difficulty breathing and fever, and can lead to respiratory failure. Involvement outside the lungs is rare but, can occur as a disseminated type affecting lymph nodes, spleen, liver, bone marrow, eyes, kidneys, thyroid, gastrointestinal tract or other organs. If occurring in the skin, it usually presents as nodular growths in the ear canals or underarms.

<span class="mw-page-title-main">Sporotrichosis</span> Medical condition

Sporotrichosis, also known as rose handler's disease, is a fungal infection that may be localised to skin, lungs, bone and joint, or become systemic. It presents with firm painless nodules that later ulcerate. Following initial exposure to Sporothrix schenckii, the disease typically progresses over a period of a week to several months. Serious complications may develop in people who have a weakened immune system.

Phycomycosis is an uncommon condition of the gastrointestinal tract and skin most commonly found in dogs and horses. The condition is caused by a variety of molds and fungi, and individual forms include pythiosis, zygomycosis, and lagenidiosis. Pythiosis is the most common type and is caused by Pythium, a type of water mould. Zygomycosis can also be caused by two types of zygomycetes, Entomophthorales and Mucorales. The latter type of zygomycosis is also referred to as mucormycosis. Lagenidiosis is caused by a Lagenidium species, which like Pythium is a water mould. Since both pythiosis and lagenidiosis are caused by organisms from the class Oomycetes, they are sometimes collectively referred to as oomycosis.

<span class="mw-page-title-main">Aspergillosis</span> Medical condition

Aspergillosis is a fungal infection of usually the lungs, caused by the genus Aspergillus, a common mould that is breathed in frequently from the air around, but does not usually affect most people. It generally occurs in people with lung diseases such as asthma, cystic fibrosis or tuberculosis, or those who have had a stem cell or organ transplant, and those who cannot fight infection because of medications they take such as steroids and some cancer treatments. Rarely, it can affect skin.

<span class="mw-page-title-main">Bacillary angiomatosis</span> Medical condition

Bacillary angiomatosis (BA) is a form of angiomatosis associated with bacteria of the genus Bartonella.

<span class="mw-page-title-main">Paracoccidioidomycosis</span> Medical condition

Paracoccidioidomycosis (PCM), also known as South American blastomycosis, is a fungal infection that can occur as a mouth and skin type, lymphangitic type, multi-organ involvement type (particularly lungs), or mixed type. If there are mouth ulcers or skin lesions, the disease is likely to be widespread. There may be no symptoms, or it may present with fever, sepsis, weight loss, large glands, or a large liver and spleen.

<span class="mw-page-title-main">Basidiobolomycosis</span> Fungal disease

Basidiobolomycosis is a fungal disease caused by Basidiobolus ranarum. It may appear as one or more painless firm nodules in the skin which becomes purplish with an edge that appears to be slowly growing outwards. A serious but less common type affects the stomach and intestine, which usually presents with abdominal pain, fever and a mass.

<span class="mw-page-title-main">Conidiobolomycosis</span> Fungal infection

Conidiobolomycosis is a rare long-term fungal infection that is typically found just under the skin of the nose, sinuses, cheeks and upper lips. It may present with a nose bleed or a blocked or runny nose. Typically there is a firm painless swelling which can slowly extend to the nasal bridge and eyes, sometimes causing facial disfigurement.

African histoplasmosis is a fungal infection caused by Histoplasma capsulatumvar. duboisii, or Histoplama duboisii (Hcd). Disease has been most often reported in Uganda, Nigeria, Zaire and Senegal, as Hcd is exclusive to Africa. In human disease it manifests differently than histoplasmosis, most often involving the skin and bones and rarely involving the lungs. Also unlike Hcc, Hcd has been reported to rarely present in those with HIV, likely due to underreporting. However, this along with the differences in Hcc and Hcd have been disputed.

<span class="mw-page-title-main">Signs and symptoms of HIV/AIDS</span>

The stages of HIV infection are acute infection, latency, and AIDS. Acute infection lasts for several weeks and may include symptoms such as fever, swollen lymph nodes, inflammation of the throat, rash, muscle pain, malaise, and mouth and esophageal sores. The latency stage involves few or no symptoms and can last anywhere from two weeks to twenty years or more, depending on the individual. AIDS, the final stage of HIV infection, is defined by low CD4+ T cell counts, various opportunistic infections, cancers, and other conditions.

Histoplasma duboisii is a saprotrophic fungus responsible for the invasive infection known as African histoplasmosis. This species is a close relative of Histoplasma capsulatum, the agent of classical histoplasmosis, and the two occur in similar habitats. Histoplasma duboisii is restricted to continental Africa and Madagascar, although scattered reports have arisen from other places usually in individuals with an African travel history. Like, H. capsulatum, H. duboisii is dimorphic – growing as a filamentous fungus at ambient temperature and a yeast at body temperature. It differs morphologically from H. capsulatum by the typical production of a large-celled yeast form. Both agents cause similar forms of disease, although H. duboisii predominantly causes cutaneous and subcutaneous disease in humans and non-human primates. The agent responds to many antifungal drug therapies used to treat serious fungal diseases.

Emmonsiosis, also known as emergomycosis, is a systemic fungal infection that can affect the lungs, generally always affects the skin and can become widespread. The lesions in the skin look like small red bumps and patches with a dip, ulcer and dead tissue in the centre.

References

  1. 1 2 3 4 5 6 7 8 9 "ICD-11 - ICD-11 for Mortality and Morbidity Statistics". icd.who.int. Retrieved 11 July 2021.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 "Talaromycosis (formerly Penicilliosis) | Fungal Diseases | CDC". www.cdc.gov. 3 March 2021. Archived from the original on 12 July 2021. Retrieved 12 July 2021.
  3. 1 2 Ning, Chuanyi; Lai, Jingzhen; Wei, Wudi; Zhou, Bo; Huang, Jiegang; Jiang, Junjun; Liang, Bingyu; Liao, Yanyan; Zang, Ning (2018). "Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis". PLOS ONE. 13 (4): e0195569. Bibcode:2018PLoSO..1395569N. doi: 10.1371/journal.pone.0195569 . ISSN   1932-6203. PMC   5886574 . PMID   29621346.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Proia, Laurie (2020). "28. The dimorphic mycoses". In Spec, Andrej; Escota, Gerome V.; Chrisler, Courtney; Davies, Bethany (eds.). Comprehensive Review of Infectious Diseases. Elsevier. pp. 420–421. ISBN   978-0-323-56866-1.
  5. 1 2 Chastain, Daniel B.; Henao-Martínez, Andrés F.; Franco-Paredes, Carlos (22 August 2017). "Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis". Current Infectious Disease Reports. 19 (10): 36. doi:10.1007/s11908-017-0592-7. ISSN   1523-3847. PMID   28831671. S2CID   26045334.
  6. 1 2 3 4 Cao, Cunwei; Xi, Liyan; Chaturvedi, Vishnu (December 2019). "Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen". Mycopathologia. 184 (6): 709–720. doi:10.1007/s11046-019-00410-2. ISSN   1573-0832. PMID   31811603. S2CID   208744711.
  7. 1 2 3 Thu, Nguyen T. M.; Chan, Jasper F. W.; Ly, Vo Trieu; Ngo, Hoa T.; Hien, Ha T. A.; Lan, Nguyen P. H.; Chau, Nguyen V. V.; Cai, Jian-Piao; Woo, Patrick C. Y.; Day, Jeremy N.; van Doorn, Rogier (21 June 2020). "Superiority of a novel Mp1p antigen detection enzyme immunoassay compared to standard BACTEC blood culture in the diagnosis of talaromycosis". Clinical Infectious Diseases. 73 (2): e330–e336. doi: 10.1093/cid/ciaa826 . ISSN   1537-6591. PMC   8282318 . PMID   32564074.
  8. 1 2 Bennett; Dolin; Blaser; Mandell; Bennett (2015). Principles and Practice of Infectious Diseases. Elsevier/Saunders.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.